by Jordana Choucair | Sep 13, 2022 | Life Sciences
An analysis conducted by the Community Oncology Alliance (COA) found that safety net hospitals are marking up the cost of drugs they buy through the federal 340B drug program by as much as 11 times the cost. The COA examined self-reported drug pricing data for 49 of...
by Jordana Choucair | Sep 12, 2022 | Life Sciences
Reportedly, Democrats said they are willing to attach pandemic preparedness legislation to the Food and Drug Administration (FDA) FY2023 funding bill if Republican senators agree to pass the House’s bipartisan mental health legislation. The House’s legislation...
by Jordana Choucair | Sep 9, 2022 | Life Sciences
The Biden administration issued a press release stating it purchased 100 million rapid at-home COVID-19 tests with its “limited funding.” Earlier this week, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra said that there is currently an...
by Jordana Choucair | Sep 7, 2022 | Life Sciences
Juul reached a tentative, $438.5 million settlement with 34 states and territories over the company’s marketing and sales practices. The lawsuit – led by attorneys general of Connecticut and Texas – alleged that the Juul deliberately engaged in an advertising campaign...
by Jordana Choucair | Sep 7, 2022 | Life Sciences
The U.S. Department of Health and Human Services (HHS) announced it awarded $19.8 million to AmerisourceBergen to expand the federal government’s monkeypox vaccine and treatment distribution. The contract will support the shipment of up to 2,500 shipments of frozen...
by Jordana Choucair | Sep 7, 2022 | Life Sciences
A new study published in Health Affairs found that drug manufacturers may have profited from donating to charities that help patients pay for costly medicines. Researchers found that the percentage of Medicare Advantage drug spending estimated to qualify for charity...
Recent Comments